Kyriazi Theo Melas - Feb 16, 2022 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Director
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Theo Melas-Kyriazi
Stock symbol
CDAKQ
Transactions as of
Feb 16, 2022
Transactions value $
$0
Form type
4
Date filed
2/18/2022, 03:05 PM
Previous filing
Jul 1, 2021
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Restricted Stock Units Award $0 +8.75K $0.00 8.75K Feb 16, 2022 Common Stock 8.75K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On February 16, 2022, the reporting person was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date.